PA
PNTG icon

PharVision Advisers’s Pennant Group PNTG Stock Holding History

PharVision Advisers’s Portfolio PNTG Stock Details PNTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,811
Closed -$222K – 937
2025
Q3 		$222K Buy
+8,811
New +$216K 0.13% 418
2025
Q1 		– Sell
-11,457
Closed -$304K – 467
2024
Q4 		$304K Buy
+11,457
New +$361K 0.26% 146

Other funds holding PNTG

VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PharVision Advisers's PNTG Position: Q4 2025 in Review

PharVision Advisers sold out of Pennant Group (PNTG) in Q4 2025, closing a stake of 8,811 shares — an estimated $222K sold.

PharVision Advisers first reported a position in PNTG in Q4 2024 and held it in 2 quarters. The position peaked at $304K in Q4 2024. 186 funds tracked by Wall St. Rank hold PNTG as of Q4 2025.

  • PharVision Advisers reported no remaining Pennant Group position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 8,811 Pennant Group shares in Q4 2025, an estimated $222K.
  • PharVision Advisers first reported a position in Pennant Group in Q4 2024 and held it in 2 quarters.
  • PharVision Advisers's Pennant Group position peaked at $304K in Q4 2024.
  • 186 funds tracked by Wall St. Rank held Pennant Group as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.